ESPINOZA OCTAVIO (Chief Financial Officer) sold 38.3% of their position (13.42K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $2.76M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1.61K
Price / share
$58.49
Trade value
$93.99K
% of position
Common Stock
Shares
+466.00
Price / share
$80.72
Trade value
$37.62K
% of position
Common Stock
Shares
−699.00
Price / share
$198.71
Trade value
$138.89K
% of position
Common Stock
Shares
−53.00
Price / share
$200.08
Trade value
$10.60K
% of position
Common Stock
Shares
−698.00
Price / share
$201.09
Trade value
$140.36K
% of position
Common Stock
Shares
−950.00
Price / share
$201.73
Trade value
$191.64K
% of position
Common Stock
Shares
−697.00
Price / share
$202.79
Trade value
$141.34K
% of position
Common Stock
Shares
−668.00
Price / share
$203.63
Trade value
$136.02K
% of position
Common Stock
Shares
−743.00
Price / share
$204.74
Trade value
$152.13K
% of position
Common Stock
Shares
−1.46K
Price / share
$205.79
Trade value
$299.84K
% of position
Common Stock
Shares
−1.59K
Price / share
$206.89
Trade value
$328.54K
% of position
Common Stock
Shares
−2.46K
Price / share
$207.91
Trade value
$510.82K
% of position
Common Stock
Shares
−3.41K
Price / share
$208.80
Trade value
$712.62K
% of position
Net shares
−11.35K
Net value
-$2.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | M · Option Exercise | +1.61K | $58.49 | $93.99K | 4.9% | 33.01K | 34.62K |
| Common Stock Direct | 3/4/2026 | M · Option Exercise | +466.00 | $80.72 | $37.62K | 1.3% | 34.62K | 35.09K |
| Common Stock Direct | 3/4/2026 | S · Sale | −699.00 | $198.71 | $138.89K | 2.0% | 35.09K | 34.39K |
| Common Stock Direct | 3/4/2026 | S · Sale | −53.00 | $200.08 | $10.60K | 0.2% | 34.39K | 34.33K |
| Common Stock Direct | 3/4/2026 | S · Sale | −698.00 | $201.09 | $140.36K | 2.0% | 34.33K | 33.63K |
| Common Stock Direct | 3/4/2026 | S · Sale | −950.00 | $201.73 | $191.64K | 2.8% | 33.63K | 32.69K |
| Common Stock Direct | 3/4/2026 | S · Sale | −697.00 | $202.79 | $141.34K | 2.1% | 32.69K | 31.99K |
| Common Stock Direct | 3/4/2026 | S · Sale | −668.00 | $203.63 | $136.02K | 2.1% | 31.99K | 31.32K |
| Common Stock Direct | 3/4/2026 | S · Sale | −743.00 | $204.74 | $152.13K | 2.4% | 31.32K | 30.58K |
| Common Stock Direct | 3/4/2026 | S · Sale | −1.46K | $205.79 | $299.84K | 4.8% | 30.58K | 29.12K |
| Common Stock Direct | 3/4/2026 | S · Sale | −1.59K | $206.89 | $328.54K | 5.5% | 29.12K | 27.53K |
| Common Stock Direct | 3/4/2026 | S · Sale | −2.46K | $207.91 | $510.82K | 8.9% | 27.53K | 25.07K |
| Common Stock Direct | 3/4/2026 | S · Sale | −3.41K | $208.80 | $712.62K | 13.6% | 25.07K | 21.66K |
| Total | −11.35K | -$2.63M | ||||||
Employee Stock Option (right to buy)
Common Stock
1.61K shares
Shares
−1.61K
Strike price
58.49
Held after
0.00
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
466.00 shares
Shares
−466.00
Strike price
80.72
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock1.61K shares | 3/4/2026 | M · Option Exercise | −1.61K | 58.49 | — | 0.00 |
| Employee Stock Option (right to buy) Direct | Common Stock466.00 shares | 3/4/2026 | M · Option Exercise | −466.00 | 80.72 | — | 0.00 |